A clinical trial of an investigational medication for the treatment of trichotillomania, also known as hair pulling disorder, in adults.
WHAT IS TRICHOTILLOMANIA?
Trichotillomania (TTM), also known as hair pulling disorder, is characterized by the repetitive pulling out of one’s hair. Hair pulling can occur in a conscious or unconscious manner and can be influenced by boredom, anxiety, frustration, or depression. Individuals with trichotillomania can have noticeable hair loss, which they may try to hide. Hair pulling can vary in its severity and location on the body (ex: head hair, eyebrows, eyelashes, or pubic hair). Thinning or bald spots on the head may be covered with hairstyles, scarves, wigs, or makeup. Those with missing eyelashes, eyebrows, or body hair, may attempt to camouflage with makeup, clothing, or other means of concealing affected areas.
People with trichotillomania often have difficulty with low self-esteem or social anxiety as a result of their hair pulling and can even lead to avoidance of intimacy and interference with job performance and career advancement opportunities. Trichotillomania can become a chronic condition if left untreated.
Trichotillomania effects about 1% of people in the United States but there are no FDA-approved therapies that can be prescribed to patients confronting TTM.
IPS Research is seeking participants for a clinical trial of an investigational medication for the treatment of trichotillomania. If you have symptoms of hair pulling as described above, you may be a candidate for this clinical trial.
Qualified participants must be:
- 18 to 45 years of age
- Recurrent hair pulling, resulting in hair loss
- Repeated attempts to decrease or stop the behavior
- Significant distress or impairment in social, occupational, or other areas of life
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel